TerminatedNCT01309581
Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression
Medication studyAges 18–65United States
Understand this study
Who could participate?
This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
- Listed locations
- New YorkSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateApril 2010
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 3
- Sponsor
- James Murrough
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01309581
- Official title
Show the full official title
Ketamine Anesthesia to Enhance Efficacy and Tolerability of Electroconvulsive Therapy in Patients With Unipolar or Bipolar Depression
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is James Murrough.
Does this study involve medication?
Yes. The study involves medication, including ketamine and Methohexital.
Who can participate?
This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
